This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Years of investment in digital, cloud and security strategy has helped Accenture evolve as a trusted and viable consulting services provider. It is currently the world’s top consultancy firm by revenues that increased 5% in 2019 with a contribution of 56% from consulting services.
Accenture (ACN) Registers a Bigger Fall Than the Market: Important Facts to Note
by Zacks Equity Research
In the closing of the recent trading day, Accenture (ACN) stood at $255.37, denoting a -4.39% move from the preceding trading day.
Accenture PLC (ACN) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Accenture (ACN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Interpublic Group Earnings Beat Estimates in Q2, Revenues Slide Y/Y
by Zacks Equity Research
IPG posts 23% y/y EPS growth in second-quarter 2025. Yet, revenues slip 6.7% and margins face sharp y/y declines.
IQVIA Earnings & Revenues Beat Estimates in Q2, Rise Y/Y
by Zacks Equity Research
IQV tops second-quarter 2025 estimates, with earnings up 6.4% and revenue rising 5.5%. It cuts the 2025 EBITDA guidance.
CYBR Stock Trades at a P/S of 12.81X: Should You Buy, Sell or Hold?
by Subham Roy
CyberArk trades at a premium, but booming identity security demand and AI-fueled growth may justify the valuation.
Accenture PLC (ACN) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Zacks.com users have recently been watching Accenture (ACN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
These Top 4 Women-Run Company Stocks Are Quietly Beating the Market
by Shrabana Mukherjee
These women-run company stocks offer high growth and stability.
4 Crypto-Centric Stocks to Watch Closely Before the Next Bitcoin Rally
by Ritujay Ghosh
As Bitcoin holds firm near $107K, CME, ACN, V, and PYPL emerge as crypto-centric stocks with growth potential in 2025.
Investors Heavily Search Accenture PLC (ACN): Here is What You Need to Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Accenture (ACN). This makes it worthwhile to examine what the stock has in store.
The Zacks Analyst Blog Highlights CME, Accenture, Visa and PayPal
by Zacks Equity Research
As Bitcoin rebounds, CME, ACN, V and PYPL gain traction with crypto offerings and rising earnings projections.
ACN Q3 Earnings & Revenues Beat on Segmental Improvement, Rise Y/Y
by Zacks Equity Research
Accenture tops third-quarter fiscal 2025 estimates with 11.5% EPS growth and a 7.7% revenue gain, yet shares dip 3.7% post-earnings.
4 Crypto-Centric Stocks to Watch as Bitcoin Rebounds to Resume Rally
by Ritujay Ghosh
As Bitcoin rebounds past $105K after a ceasefire, CME, ACN, V and PYPL emerge as crypto-centric stocks with upside potential.
Paychex to Report Q4 Earnings: Here's What to Expect From the Stock
by Zacks Equity Research
PAYX is set to post fourth-quarter fiscal 2025 results, with revenues rising 9.3% y/y and earnings growing 6.3% on segment gains and margin strength.
Company News for Jun 23, 2025
by Zacks Equity Research
Companies in The News Are: KR,DRI,KMX,ACU
Accenture (ACN) Reliance on International Sales: What Investors Need to Know
by Zacks Equity Research
Evaluate Accenture's (ACN) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Accenture Earnings Beat Estimates in Q3, Revenues Increase Y/Y
by Zacks Equity Research
ACN tops third-quarter fiscal 2025 estimates with 11.5% y/y EPS growth and 7.7% revenue gain, lifting the FY25 guidance across key financial metrics.
Accenture (ACN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
The headline numbers for Accenture (ACN) give insight into how the company performed in the quarter ended May 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Accenture (ACN) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Accenture (ACN) delivered earnings and revenue surprises of 5.76% and 2.56%, respectively, for the quarter ended May 2025. Do the numbers hold clues to what lies ahead for the stock?
Accenture Set to Report Q3 Earnings: Here's What You Should Know
by Zacks Equity Research
ACN is set to report third-quarter fiscal 2025 results, with growth across all segments and a 5.1% y/y EPS increase.
JBL Set to Report Q3 Results: Will Revenue Growth Boost Earnings?
by Zacks Equity Research
Jabil targets fiscal Q3 revenue growth fueled by AI, cloud and data center momentum, with innovation and cash flow in focus.
Stay Ahead of the Game With Accenture (ACN) Q3 Earnings: Wall Street's Insights on Key Metrics
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Accenture (ACN), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended May 2025.
Oracle, Accenture and Lennar are part of Zacks Earnings Preview
by Zacks Equity Research
Oracle, Accenture and Lennar headline this week's earnings watch as Q2 growth estimates hit a post-COVID low.
Previewing Q2 Earnings Expectations
by Sheraz Mian
The current expectation is for Q2 earnings to increase by +5.1% on +3.8% higher revenues YoY, which will be a material deceleration from the +11.9% earnings growth pace in Q1 on +3.6% higher revenues. What else should investors know?
Accenture (ACN) Outperforms Broader Market: What You Need to Know
by Zacks Equity Research
In the most recent trading session, Accenture (ACN) closed at $320.92, indicating a +1.36% shift from the previous trading day.
Accenture Stock Drops 12% in 6 Months: Is Now the Right Time to Buy?
by Zacks Equity Research
Given the decline in ACN's share price, we evaluate its current position to find out whether it offers a good investment opportunity now.